Incyte Stock Today

INCY -  USA Stock  

USD 75.34  0.55  0.74%

Market Performance
6 of 100
Odds Of Distress
Less than 46
Incyte Corp is trading at 75.34 as of the 24th of January 2022; that is 0.74 percent increase since the beginning of the trading day. The stock's open price was 74.79. Incyte Corp has 46 percent odds of going through some form of financial distress in the next two years and did not have a very good performance for investor during the last 90 trading days. Equity ratings for Incyte Corp are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of December 2021 and ending today, the 24th of January 2022. Click here to learn more.
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company was incorporated in 1991 and is headquartered in Wilmington, Delaware. The company has 220.89 M outstanding shares of which 4.56 M shares are currently shorted by private and institutional investors with about 1.92 trading days to cover. More on Incyte Corp

Incyte Corp Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. Incyte Corp's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Incyte Corp or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Incyte Corp has a frail financial position based on the latest SEC disclosures
Over 94.0% of the company shares are owned by institutional investors
Latest headline from Acquisition by Dashyant Dhanak of 15054 shares of Incyte Corp subject to Rule 16b-3
Incyte Corp Fama & French Business Services
Business Services
Fama & French Classification
Incyte Corp SEC Filings
Incyte Corp SEC Filings Security & Exchange Commission EDGAR Reports
Legal NameIncyte Corp
ChairmanHerve Hoppenot  (View All)
Thematic Classification
Currently Active Investing Idea (view all)
Average Analyst Recommendation
Analysts covering Incyte Corp report their recommendations after researching Incyte Corp's financial statements, talking to executives and customers, or listening in on Incyte Corp's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Incyte Corp. The Incyte consensus assessment is calculated by taking the average forecast from all of the analysts covering Incyte Corp.
Piotroski F Score
Piotroski F-Score is a popular financial indicator that puts together nine criteria to evaluate the financial strength of Incyte Corp based on its profitability, leverage, liquidity, source of funds, and operating efficiency. It is an academic score (developed by Joseph Piotroski in 2002) to determine the current strength of Incyte Corp financial position. Scores of 8 and 9 are usually classified as strong value stocks, whereas scores of 2 or below are considered weak value stocks.
 3 - FrailDetails
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares235.6 M250.8 M
Notably Down
Slightly volatile
Weighted Average Shares Diluted236.7 M250.8 M
Notably Down
Slightly volatile
Net Cash Flow from Operations(147.1 M)(143.3 M)
Fairly Down
Total Assets4.4 B4.1 B
Significantly Up
Slightly volatile
Total LiabilitiesB1.1 B
Notably Down
Slightly volatile
Current Assets2.9 B2.7 B
Significantly Up
Slightly volatile
Current Liabilities783.2 M725.9 M
Significantly Up
Slightly volatile
Total Debt32.2 M31.4 M
Fairly Up
Slightly volatile
Return on Average Assets(0.11)(0.11)
Slightly volatile
Gross Margin0.860.86
Slightly volatile
Asset Turnover0.930.96
Sufficiently Down
Slightly volatile
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Incyte Corp's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong BuyUndervalued
Financial Strength
Incyte Corp's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Incyte Corp's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Incyte Corp's financial leverage. It provides some insight into what part of Incyte Corp's total assets is financed by creditors.
Share Download
Share Download
By using current balance sheet information, investors can analyze the liability, assets, and equity on Incyte Corp's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Incyte Corp deploys its capital and how much of that capital is borrowed.
Incyte Corp cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company currently holds 58.58 M in liabilities with Debt to Equity (D/E) ratio of 0.02, which may suggest the company is not taking enough advantage from borrowing. Incyte Corp has a current ratio of 3.86, suggesting that it is liquid enough and is able to pay its financial obligations when due.

Operating Cash Flow

(147.06 Million)Share
Incyte Corp (INCY) is traded on NASDAQ Exchange in USA. It is located in 1801 Augustine Cut Off, Wilmington, DE 19803, United States and employs 1,773 people. Incyte Corp is listed under Business Services category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with current market capitalization of 16.52 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Incyte Corp's market, we take the total number of its shares issued and multiply it by Incyte Corp's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Incyte Corp conducts business under Healthcare sector and is part of Biotechnology industry. The entity has 220.89 M outstanding shares of which 4.56 M shares are currently shorted by private and institutional investors with about 1.92 trading days to cover. Incyte Corp currently holds about 2.28 B in cash with 741.46 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 10.34.
Check Incyte Corp Probability Of Bankruptcy
Incyte Corp has a total of two hundred twenty million eight hundred ninety thousand outstanding shares. The majority of Incyte Corp outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Incyte Corp to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Incyte Corp. Please pay attention to any change in the institutional holdings of Incyte Corp as this could imply that something significant has changed or about to change at the company. Please note that no matter how much assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Ownership Allocation (%)

Check Incyte Ownership Details

Incyte Stock Price Odds Analysis

What are Incyte Corp's target price odds to finish over the current price? Based on a normal probability distribution, the odds of Incyte Corp jumping above the current price in 90 days from now is about 5.25%. The Incyte Corp probability density function shows the probability of Incyte Corp stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Incyte Corp has a beta of 0.3831. This usually indicates as returns on the market go up, Incyte Corp average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Incyte Corp will be expected to be much smaller as well. Additionally, the company has an alpha of 0.2372, implying that it can generate a 0.24 percent excess return over DOW after adjusting for the inherited market risk (beta).
 Odds Down 75.34HorizonTargetOdds Up 75.34 
94.68%90 days
Based on a normal probability distribution, the odds of Incyte Corp to move above the current price in 90 days from now is about 5.25 (This Incyte Corp probability density function shows the probability of Incyte Stock to fall within a particular range of prices over 90 days) .

Incyte Corp Historical Income Statement

Incyte Corp Income Statement is one of the three primary financial statements used for reporting Incyte's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Incyte Corp revenue and expense. Incyte Corp Income Statement primarily focuses on the company's revenues and expenses during a particular period.
Incyte Corp Direct Expenses is fairly stable at the moment as compared to the past year. Incyte Corp reported Direct Expenses of 118.2 Million in 2021. Cost of Revenue is likely to rise to about 163 M in 2022, whereas Consolidated Income is likely to drop (349 M) in 2022. View More Fundamentals

Incyte Stock Against Markets

Picking the right benchmark for Incyte Corp stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Incyte Corp stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Incyte Corp is critical whether you are bullish or bearish towards Incyte Corp at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Incyte Corp without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Companies Directory Now


Companies Directory

Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
All  Next Launch Module

Incyte Corp Corporate Directors

Incyte Corp corporate directors refer to members of an Incyte Corp board of directors. The board of directors generally takes responsibility for the Incyte Corp's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Incyte Corp's board members must vote for the resolution. The Incyte Corp board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Paul Friedman - DirectorProfile
Jacqualyn Fouse - DirectorProfile
Paul Clancy - DirectorProfile
Wendy Dixon - Independent DirectorProfile
Please see Risk vs Return Analysis. Note that the Incyte Corp information on this page should be used as a complementary analysis to other Incyte Corp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Complementary Tools for Incyte Stock analysis

When running Incyte Corp price analysis, check to measure Incyte Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Incyte Corp is operating at the current time. Most of Incyte Corp's value examination focuses on studying past and present price action to predict the probability of Incyte Corp's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Incyte Corp's price. Additionally, you may evaluate how the addition of Incyte Corp to your portfolios can decrease your overall portfolio volatility.
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Money Managers
Screen money managers from public funds and ETFs managed around the world
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Transaction History
View history of all your transactions and understand their impact on performance
Is Incyte Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Incyte Corp. If investors know Incyte will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Incyte Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Incyte Corp is measured differently than its book value, which is the value of Incyte that is recorded on the company's balance sheet. Investors also form their own opinion of Incyte Corp's value that differs from its market value or its book value, called intrinsic value, which is Incyte Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Incyte Corp's market value can be influenced by many factors that don't directly affect Incyte Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Incyte Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine Incyte Corp value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Incyte Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.